3,025
Views
46
CrossRef citations to date
0
Altmetric
Reviews

A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with ‘standard of care’ medicinal and procedures not requiring regulatory approval for use

, , &
Pages 885-906 | Received 04 Jan 2017, Accepted 10 May 2017, Published online: 28 Jun 2017

References

  • Abdel-Mageed AS, Senagore AJ, Pietryga DW, Connors RH, Giambernardi TA, Hay RV, Deng W. 2009. Intravenous administration of mesenchymal stem cells genetically modified with extracellular superoxide dismutase improves survival in irradiated mice. Blood. 113:1201–1203.
  • Aggarwal BB, Ichikawa H. 2005. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle. 4:1201–1215.
  • Alvarez E, Fey EG, Valax P, Yim Z, Peterson JD, Mesri M, Jeffers M, Dindinger M, Twomlow N, Ghatpande A, et al. 2003. Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis. Clin Cancer Res. 9:3454–3461.
  • Alvarez E, Gerlach VL, Gerwien RW, Fey EG, Watkins BA, Hahne WF, Sonis ST. 2005. Single-dose prevention or short-term treatment with fibroblast growth factor-20 (CG53135-05) reduces the severity and duration of oral mucositis. Support Cancer Ther. 2:122–127.
  • Amgen Inc. 2015a. Neulasta (pegfilgrastim) injection for subcutaneous use [Internet]. Available from: http://pi.amgen.com/united_states/neulasta/neulasta_pi_hcp_english.pdf
  • Amgen Inc. 2015b. Neupogen (filgrastim) injection for subcutaneous or intravenous use [Internet]. Available from: http://pi.amgen.com/united_states/neupogen/neupogen_pi_hcp_english.pdf
  • Andic F, Garipagaoglu M, Yurdakonar E, Tuncel N, Kucuk O. 2009. Lycopene in the prevention of gastrointestinal toxicity of radiotherapy. Nutr Cancer. 61:784–788.
  • Arora R, editor. 2008. Herbal Radioimmunomodulators: applications in medicine, homeland defense and space. Oxfordshire, UK: CAB International.
  • Berbee M, Fu Q, Boerma M, Pathak R, Zhou D, Kumar KS, Hauer-Jensen M. 2011. Reduction of radiation-induced vascular nitrosative stress by the vitamin E analog γ-tocotrienol: evidence of a role for tetrahydrobiopterin. Int J Radiat Oncol Biol Phys. 79:884–891.
  • Berbee M, Fu Q, Kumar KS, Hauer-Jensen M. 2010. Novel strategies to ameliorate radiation injury: a possible role for tetrahydrobiopterin. Curr Drug Targets. 11:1366–1374.
  • Berhane H, Shinde A, Kalash R, Xu K, Epperly MW, Goff J, Franicola D, Zhang X, Dixon T, Shields D, et al. 2014. Amelioration of radiation-induced oral cavity mucositis and distant bone marrow suppression in fanconi anemia Fancd2-/- (FVB/N) mice by intraoral GS-nitroxide JP4-039. Radiat Res. 182:35–49.
  • Bhanja P, Saha S, Kabarriti R, Liu L, Roy-Chowdhury N, Roy-Chowdhury J, Sellers RS, Alfieri AA, Guha C. 2009. Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice. PLoS One. 4:e8014
  • Brown SL, Kolozsvary A, Liu J, Jenrow KA, Ryu S, Kim JH. 2010. Antioxidant diet supplementation starting 24 hours after exposure reduces radiation lethality. Radiat Res. 173:462–468.
  • Carney DH, Olszewska-Pazdrak B. 2008. Could rusalatide acetate be the future drug of choice for diabetic foot ulcers and fracture repair? Expert Opin Pharmacother. 9:2717–2726.
  • Cary LH, Ngudiankama BF, Salber RE, Ledney GD, Whitnall MH. 2012. Efficacy of radiation countermeasures depends on radiation quality. Radiat Res. 177:663–675.
  • Casey-Sawicki K, Zhang M, Kim S, Zhang A, Zhang SB, Zhang Z, Singh R, Yang S, Swarts S, Vidyasagar S, et al. 2014. A basic fibroblast growth factor analog for protection and mitigation against acute radiation syndromes. Health Phys. 106:704–712.
  • Celldex Therapeutics. 2016. CDX-301: a Flt3L clinical program focused first on hematopoietic stem cell transplantation [Internet]. Available from: http://www.celldex.com/pipeline/cdx-301.php
  • Charrier S, Michaud A, Badaoui S, Giroux S, Ezan E, Sainteny F, Corvol P, Vainchenker W. 2004. Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells. Blood 104:978–985.
  • Chawla R, Arora R, Singh S, Sagar RK, Sharma RK, Kumar R, Sharma A, Gupta ML, Singh S, Prasad J, et al. 2007. Radioprotective and antioxidant activity of fractionated extracts of berries of Hippophae rhamnoides. J Med Food. 10:101–109.
  • Chen H, Xiang H, Wu B, Zhang X, Li M, Liu J, Li J, Ren Z, Du B, He K, et al. 2016. Manganese superoxide dismutase gene modified mesenchymal stem cells attenuates acute radiation-induced lung injury. Hum Gene Ther. [Epub ahead of print]. PMID:27806643. doi: 10.1089/hum.2016.106
  • Chisi JE, Briscoe CV, Ezan E, Genet R, Riches AC, Wdzieczak-Bakala J. 2000. Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation. Br J Haematol. 109:563–570.
  • Cho YJ, Yi CO, Jeon BT, Jeong YY, Kang GM, Lee JE, Roh GS, Lee JD. 2013. Curcumin attenuates radiation-induced inflammation and fibrosis in rat lungs. Korean J Physiol Pharmacol. 17:267–274.
  • Chung EJ, Hudak K, Horton JA, White A, Scroggins BT, Vaswani S, Citrin D. 2014. Transforming growth factor alpha is a critical mediator of radiation lung injury. Radiat Res. 182:350–362.
  • Clinical Trial.gov. 2016. Romiplostim in increasing low platelet counts in patients with multiple myeloma receiving chemotherapy [Internet]. Available from: https://clinicaltrials.gov/ct2/show/NCT01676961
  • Cohen EP, Fish BL, Moulder JE. 1992. Treatment of radiation nephropathy with captopril. Radiat Res. 132:346–350.
  • Cohen EP, Irving AA, Drobyski WR, Klein JP, Passweg J, Talano JA, Juckett MB, Moulder JE. 2008. Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial. Int J Radiat Oncol Biol Phys. 70:1546–1551.
  • Coleman CN, Hrdina C, Bader JL, Norwood A, Hayhurst R, Forsha J, Yeskey K, Knebel A. 2009. Medical response to a radiologic/nuclear event: integrated plan from the Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services. Ann Emerg Med. 53:213–222.
  • Colon J, Herrera L, Smith J, Patil S, Komanski C, Kupelian P, Seal S, Jenkins DW, Baker CH. 2009. Protection from radiation-induced pneumonitis using cerium oxide nanoparticles. Nanomedicine. 5:225–231.
  • Colon J, Hsieh N, Ferguson A, Kupelian P, Seal S, Jenkins DW, Baker CH. 2010. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine. 6:698–705.
  • Copp RR, Peebles DD, Soref CM, Fahl WE. 2013. Radioprotective efficacy and toxicity of a new family of aminothiol analogs. Int J Radiat Biol. 89:485–492.
  • Dainiak N, Gent RN, Carr Z, Schneider R, Bader J, Buglova E, Chao N, Coleman CN, Ganser A, Gorin C, et al. 2011. Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems. Disaster Med Public Health Prep. 5:183–201.
  • Dainiak N, Waselenko JK, Armitage JO, MacVittie TJ, Farese AM. 2003. The hematologist and radiation casualties. Hematol Am Soc Hematol Educ Program. 2003:473–496.
  • Davis TA, Landauer MR, Mog SR, Barshishat-Kupper M, Zins SR, Amare MF, Day RM. 2010. Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation. Exp Hematol. 38:270–281.
  • Day RM, Davis TA, Barshishat-Kupper M, McCart EA, Tipton AJ, Landauer MR. 2013. Enhanced hematopoietic protection from radiation by the combination of genistein and captopril. Int Immunopharmacol. 15:348–356.
  • de Lau WB, Snel B, Clevers HC. 2012. The R-spondin protein family. Genome Biol. 13:242.
  • Del Priore G, Gudipudi DK, Montemarano N, Restivo AM, Malanowska-Stega J, Arslan AA. 2010. Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia. Gynecol Oncol. 116:464–467.
  • Deng W, Kimura Y, Gududuru V, Wu W, Balogh A, Szabo E, Thompson KE, Yates CR, Balazs L, Johnson LR, et al. 2015. Mitigation of the hematopoietic and gastrointestinal acute radiation syndrome by octadecenyl thiophosphate, a small molecule mimic of lysophosphatidic acid. Radiat Res. 183:465–475.
  • Deng W, Shuyu E, Tsukahara R, Valentine WJ, Durgam G, Gududuru V, Balazs L, Manickam V, Arsura M, VanMiddlesworth L, et al. 2007. The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury. Gastroenterology. 132:1834–1851.
  • DiCarlo AL, Maher C, Hick JL, Hanfling D, Dainiak N, Chao N, Bader JL, Coleman CN, Weinstock DM. 2011. Radiation injury after a nuclear detonation: Medical consequences and the need for scarce resources allocation. Disaster Med Public Health Prep. 5(Suppl.1):S32–S44.
  • Doan PL, Himburg HA, Helms K, Russell JL, Fixsen E, Quarmyne M, Harris JR, Deoliviera D, Sullivan JM, Chao NJ, et al. 2013. Epidermal growth factor regulates hematopoietic regeneration after radiation injury. Nat Med. 19:295–304.
  • Durante M. 2014. Space radiation protection: destination Mars. Life Sci Space Res (Amst). 1:2–9.
  • Epperly MW, Bray JA, Krager S, Berry LM, Gooding W, Engelhardt JF, Zwacka R, Travis EL, Greenberger JS. 1999. Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis. Int J Radiat Oncol Biol Phys. 43:169–181.
  • Epperly MW, Chaillet JR, Kalash R, Shaffer B, Goff J, Franicola D, Zhang X, Dixon T, Houghton F, Wang H, et al. 2013. Conditional radioresistance of Tet-inducible manganese superoxide dismutase bone marrow stromal cell lines. Radiat Res. 180:189–204.
  • Epperly MW, Defilippi S, Sikora C, Gretton J, Kalend A, Greenberger JS. 2000. Intratracheal injection of manganese superoxide dismutase (MnSOD) plasmid/liposomes protects normal lung but not orthotopic tumors from irradiation. Gene Ther. 7:1011–1018.
  • Epperly MW, Dixon T, Wang H, Schlesselman J, Franicola D, Greenberger JS. 2008. Modulation of radiation-induced life shortening by systemic intravenous MnSOD-plasmid liposome gene therapy. Radiat Res. 170:437–443.
  • Epperly MW, Goff JP, Franicola D, Wang H, Wipf P, Li S, Greenberger JS. 2014. Esophageal radioprotection by swallowed JP4-039/F15 in thoracic-irradiated mice with transgenic lung tumors. In Vivo. 28:435–440.
  • Epperly MW, Gretton JA, DeFilippi SJ, Greenberger JS, Sikora CA, Liggitt D, Koe G. 2001a. Modulation of radiation-induced cytokine elevation associated with esophagitis and esophageal stricture by manganese superoxide dismutase-plasmid/liposome (SOD2-PL) gene therapy. Radiat Res. 155:2–14.
  • Epperly MW, Gretton JE, Sikora CA, Jefferson M, Bernarding M, Nie S, Greenberger JS. 2003. Mitochondrial localization of superoxide dismutase is required for decreasing radiation-induced cellular damage. Radiat Res. 160:568–578.
  • Epperly MW, Kagan VE, Sikora CA, Gretton JE, Defilippi SJ, Bar-Sagi D, Greenberger JS. 2001b. Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) administration protects mice from esophagitis associated with fractionated radiation. Int J Cancer. 96:221–231.
  • Epperly MW, Sacher JR, Krainz T, Zhang X, Wipf P, Liang M, Fisher R, Li S, Wang H, Greenberger JS. 2017. Effectiveness of analogs of the GS-nitroxide, JP4-039, as total body irradiation mitigators. In Vivo. 31:39–43.
  • Epperly MW, Wang H, Jones JA, Dixon T, Montesinos CA, Greenberger JS. 2011. Antioxidant-chemoprevention diet ameliorates late effects of total-body irradiation and supplements radioprotection by MnSOD-plasmid liposome administration. Radiat Res. 175:759–765.
  • Fan S, Meng Q, Xu J, Jiao Y, Zhao L, Zhang X, Sarkar FH, Brown ML, Dritschilo A, Rosen EM. 2013. DIM (3,3′-diindolylmethane) confers protection against ionizing radiation by a unique mechanism. Proc Natl Acad Sci USA. 110:18650–18655.
  • Farese AM, Cohen MV, Katz BP, Smith CP, Gibbs A, Cohen DM, MacVittie TJ. 2013. Filgrastim improves survival in lethally irradiated nonhuman primates. Radiat Res. 179:89–100.
  • Farese AM, Cohen MV, Stead RB, Jackson W, 3rd, Macvittie TJ. 2012. Pegfilgrastim administered in an abbreviated schedule, significantly improved neutrophil recovery after high-dose radiation-induced myelosuppression in rhesus macaques. Radiat Res. 178:403–413.
  • Farese AM, Hunt P, Grab LB, MacVittie TJ. 1996. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J Clin Invest. 97:2145–2151.
  • Fife C, Mader JT, Stone J, Brill L, Satterfield K, Norfleet A, Zwernemann A, Ryaby JT, Carney DH. 2007. Thrombin peptide Chrysalin stimulates healing of diabetic foot ulcers in a placebo-controlled phase I/II study. Wound Repair Regen. 15:23–34.
  • Floratou K, Giannopoulou E, Antonacopoulou A, Karakantza M, Adonakis G, Kardamakis D, Matsouka P. 2012. Oxidative stress due to radiation in CD34(+) hematopoietic progenitor cells: protection by IGF-1. J Radiat Res. 53:672–685.
  • Flynn DF, Goans RE. 2006. Nuclear terrorism: triage and medical management of radiation and combined-injury casualties. Surg Clin North Am. 86:601–636.
  • Fu Q, Berbee M, Boerma M, Wang J, Schmid HA, Hauer-Jensen M. 2009. The somatostatin analog SOM230 (pasireotide) ameliorates injury of the intestinal mucosa and increases survival after total-body irradiation by inhibiting exocrine pancreatic secretion. Radiat Res. 171:698–707.
  • Fu Q, Berbee M, Wang W, Boerma M, Wang J, Schmid HA, Hauer-Jensen M. 2011. Preclinical evaluation of Som230 as a radiation mitigator in a mouse model: postexposure time window and mechanisms of action. Radiat Res. 175:728–735.
  • Fukumoto R, Burns TM, Kiang JG. 2014. Ciprofloxacin enhances stress erythropoiesis in spleen and increases survival after whole-body irradiation combined with skin-wound trauma. PLoS One. 9:e90448.
  • Fukumoto R, Cary LH, Gorbunov NV, Lombardini ED, Elliott TB, Kiang JG. 2013. Ciprofloxacin modulates cytokine/chemokine profile in serum, improves bone marrow repopulation, and limits apoptosis and autophagy in ileum after whole body ionizing irradiation combined with skin-wound trauma. PLoS One. 8:e58389.
  • Furth FW, Coulter MP, Miller RW, Howland JW, Swisher SN. 1953. The treatment of the acute radiation syndrome in dogs with aureomycin and whole blood. J Lab Clin Med 41:918–928.
  • Gaidamakova EK, Myles IA, McDaniel DP, Fowler CJ, Valdez PA, Naik S, Gayen M, Gupta P, Sharma A, Glass PJ, et al. 2012. Preserving immunogenicity of lethally irradiated viral and bacterial vaccine epitopes using a radio- protective Mn2+-Peptide complex from Deinococcus. Cell Host Microbe. 12:117–124.
  • George KC, Hebbar SA, Kale SP, Kesavan PC. 1999. Caffeine protects mice against whole-body lethal dose of gamma-irradiation. J Radiol Prot. 19:171–176.
  • Gesierich A, Niroomand F, Tiefenbacher CP. 2003. Role of human GTP cyclohydrolase I and its regulatory protein in tetrahydrobiopterin metabolism. Basic Res Cardiol. 98:69–75.
  • Ghosh SN, Zhang R, Fish BL, Semenenko VA, Li XA, Moulder JE, Jacobs ER, Medhora M. 2009. Renin-Angiotensin system suppression mitigates experimental radiation pneumonitis. Int J Radiat Oncol Biol Phys. 75:1528–1536.
  • Goans RE. 2002. Clinical care of the radiation-accident patient: patient presentation, assessment and initial diagnosis. In: Ricks RC, Berger ME, O’Hara FM, editors. The medical basis for victims. Boca Raton (FL): Partheon Publishing Group.
  • Goel HC, Gupta D, Gupta S, Garg AP, Bala M. 2005. Protection of mitochondrial system by Hippophae rhamnoides L. against radiation-induced oxidative damage in mice. J Pharm Pharmacol. 57:135–143.
  • Goel HC, Prasad J, Singh S, Sagar RK, Kumar IP, Sinha AK. 2002. Radioprotection by a herbal preparation of Hippophae rhamnoides, RH-3, against whole body lethal irradiation in mice. Phytomedicine. 9:15–25.
  • Goel HC, Salin CA, Prakash H. 2003. Protection of jejunal crypts by RH-3 (a preparation of Hippophae rhamnoides) against lethal whole body gamma irradiation. Phytother Res. 17:222–226.
  • Goff JP, Epperly MW, Dixon T, Wang H, Franicola D, Shields D, Wipf P, Li S, Gao X, Greenberger JS. 2011. Radiobiologic effects of GS-nitroxide (JP4-039) on the hematopoietic syndrome. In Vivo. 25:315–323.
  • Gong W, Guo M, Han Z, Wang Y, Yang P, Xu C, Wang Q, Du L, Li Q, Zhao H, et al. 2016. Mesenchymal stem cells stimulate intestinal stem cells to repair radiation-induced intestinal injury. Cell Death Dis. 7:e2387.
  • Gorin NC, Fliedner TM, Gourmelon P, Ganser A, Meineke V, Sirohi B, Powles R, Apperley J. 2006. Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents. Ann Hematol. 85:671–679.
  • Greenberger JS. 2008. Gene therapy approaches for stem cell protection. Gene Ther. 15:100–108.
  • Gu X, Wang X, Xiao H, Ma G, Cui L, Li Y, Zhou H, Liang W, Zhao B, Li K. 2015. Silencing of R-Spondin1 increases radiosensitivity of glioma cells. Oncotarget. 6:9756–9765.
  • Guo H, Seixas-Silva JA Jr, Epperly MW, Gretton JE, Shin DM, Bar-Sagi D, Archer H, Greenberger JS. 2003. Prevention of radiation-induced oral cavity mucositis by plasmid/liposome delivery of the human manganese superoxide dismutase (SOD2) transgene. Radiat Res. 159:361–370.
  • Gupta P, Gayen M, Smith JT, Gaidamakova EK, Matrosova VY, Grichenko O, Knollmann-Ritschel B, Daly MJ, Kiang JG, Maheshwari RK. 2016. MDP: A Deinococcus Mn2+-decapeptide complex protects mice from ionizing radiation. PLoS One. 11:e0160575.
  • Gusev IA, Guskova AK, Mettler FA. 2001. Medical Management of Radiation Accidents. Boca Raton (FL): CRC Press.
  • Hall S, Rudrawar S, Zunk M, Bernaitis N, Arora D, McDermott CM, Anoopkumar-Dukie S. 2016. Protection against radiotherapy-induced toxicity. Antioxidants (Basel). 5(3):pii:E22. PMID: 27399787. doi: 10.3390/antiox5030022
  • Hauer-Jensen M, Wang J, Boerma M, Fu Q, Denham JW. 2007. Radiation damage to the gastrointestinal tract: mechanisms, diagnosis, and management. Curr Opin Support Palliat Care. 1:23–29.
  • Haydont V, Bourgier C, Pocard M, Lusinchi A, Aigueperse J, Mathe D, Bourhis J, Vozenin-Brotons MC. 2007. Pravastatin Inhibits the Rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats. Clin Cancer Res. 13:5331–5340.
  • Heath EI, Heilbrun LK, Li J, Vaishampayan U, Harper F, Pemberton P, Sarkar FH. 2010. A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3′-Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. Am J Transl Res. 2:402–411.
  • Hebbar SA, Mitra AK, George KC, Verma NC. 2002. Caffeine ameliorates radiation-induced skin reactions in mice but does not influence tumour radiation response. J Radiol Prot. 22:63–69.
  • Hepgul G, Tanrikulu S, Unalp HR, Akguner T, Erbil Y, Olgac V, Ademoglu E. 2010. Preventive effect of pentoxifylline on acute radiation damage via antioxidant and anti-inflammatory pathways. Dig Dis Sci. 55:617–625.
  • Himburg HA, Muramoto GG, Daher P, Meadows SK, Russell JL, Doan P, Chi JT, Salter AB, Lento WE, Reya T, et al. 2010. Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells. Nat Med. 16:475–482.
  • Hrdina CM, Coleman CN, Bogucki S, Bader JL, Hayhurst RE, Forsha JD, Marcozzi D, Yeskey K, Knebel AR. 2009. The ‘RTR medical response system for nuclear and radiological mass-casualty incidents: a functional TRiage-TReatment-TRansport medical response model’. Prehosp Disaster Med. 24:167–178.
  • Hubner KF, Fry SA. 1979. The medical basis of radiation accident preparedness. Amsterdam: Elsevier.
  • Ishii T, Futami S, Nishida M, Suzuki T, Sakamoto T, Suzuki N, Maekawa K. 2001. Brief note and evaluation of acute-radiation syndrome and treatment of a Tokai-mura criticality accident patient. JRR. 42(Suppl.):S167–S182.
  • Islam A, Bolduc DL, Zhai M, Kiang JG, Swift JM. 2015. Captopril increases survival after whole-body ionizing irradiation but decreases survival when combined with skin-burn trauma in mice. Radiat Res. 184:273–279.
  • Jackson DP, Sorensen DK, Cronkite EP, Bond VP, Fliedner TM. 1959. Effectiveness of transfusions of fresh and lyophilized platelets in controlling bleeding due to thrombocytopenia. J Clin Invest. 38:1689–1697.
  • Jarrett DG. 1999. Medical management of radiological casualties handbook. Bethesda. MD: Armed Forces Radiobiology Research Institute.
  • Jia D, Koonce NA, Griffin RJ, Jackson C, Corry PM. 2010. Prevention and mitigation of acute death of mice after abdominal irradiation by the antioxidant N-acetyl-cysteine (NAC). Radiat Res. 173:579–589.
  • Kalivendi S, Hatakeyama K, Whitsett J, Konorev E, Kalyanaraman B, Vasquez-Vivar J. 2005. Changes in tetrahydrobiopterin levels in endothelial cells and adult cardiomyocytes induced by LPS and hydrogen peroxide – a role for GFRP? Free Radic Biol Med. 38:481–491.
  • Kantara C, Moya SM, Houchen CW, Umar S, Ullrich RL, Singh P, Carney DH. 2015. Novel regenerative peptide TP508 mitigates radiation-induced gastrointestinal damage by activating stem cells and preserving crypt integrity. Lab Invest. 95:1222–1233.
  • Kaplan JZ. 1985. Care of thermally injured victims of a thermonuclear explosion. In: Walker RI, Gruber DF, Macvittie TJ, Conklin JJ, editors. Medical consequences of nuclear warfare pathophysiology of combined injury and trauma. Baltimore (MD): University Park Press.
  • Khan A, Manna K, Chinchubose Das DK, Sinha M, Kesh SB, Das U, Dey RS, Banerji A, Dey S. 2014. Sea Buckthorn (Hippophae rhamnoides L.) leaf extract ameliorates the gamma radiation mediated DNA damage and hepatic alterations. Indian J Exp Biol. 52:952–964.
  • Kim K, Pollard JM, Norris AJ, McDonald JT, Sun Y, Micewicz E, Pettijohn K, Damoiseaux R, Iwamoto KS, Sayre JW, et al. 2009. High-throughput screening identifies two classes of antibiotics as radioprotectors: tetracyclines and fluoroquinolones. Clin Cancer Res. 15:7238–7245.
  • Kim SG, Nam SY, Kim CW. 1998. In vivo radioprotective effects of oltipraz in gamma-irradiated mice. Biochem Pharmacol. 55:1585–1590.
  • Kiss GN, Lee SC, Fells JI, Liu J, Valentine WJ, Fujiwara Y, Thompson KE, Yates CR, Sumegi B, Tigyi G. 2013. Mitigation of radiation injury by selective stimulation of the LPA(2) receptor. Biochim Biophys Acta. 1831:117–125.
  • Kluwe J, Mencin A, Schwabe RF. 2009. Toll-like receptors, wound healing, and carcinogenesis. J Mol Med. 87:125–138.
  • Kma L. 2014. Plant extracts and plant-derived compounds: promising players in a countermeasure strategy against radiological exposure. Asian Pac J Cancer Prev. 15:2405–2425.
  • Kma L, Gao F, Fish BL, Moulder JE, Jacobs ER, Medhora M. 2012. Angiotensin converting enzyme inhibitors mitigate collagen synthesis induced by a single dose of radiation to the whole thorax. J Radiat Res. 53:10–17.
  • Koh WJ, Stelzer KJ, Peterson LM, Staker BL, Ward WF, Russell KJ, Griffin TW. 1995. Effect of pentoxifylline on radiation-induced lung and skin toxicity in rats. Int J Radiat Oncol Biol Phys. 31:71–77.
  • Kumar A, Kochar A, Sharma D, Johari P, Kumar M, Prendergast P, Kimura H. 2011. Antimutagenic and radioprotective effects of oltipraz. Poster presented at: 14th International Congress of Radiation Research. Warsaw, Poland.
  • Kumar KS, Papas A, Seed TM, Srinivasan V. 2006. Radiation protection by gamma-tocotrienol. USA Patent Application PCT/US2004/00452.
  • Lazo JS, Sharlow ER, Epperly MW, Lira A, Leimgruber S, Skoda EM, Wipf P, Greenberger JS. 2013. Pharmacologic profiling of phosphoinositide 3-kinase inhibitors as mitigators of ionizing radiation-induced cell death. J Pharmacol Exp Ther. 347:669–680.
  • Leask A, Abraham DJ. 2004. TGF-beta signaling and the fibrotic response. FASEB J. 18:816–827.
  • Ledney GD, Elliott TB. 2010. Combined injury: factors with potential to impact radiation dose assessments. Health Phys. 98:145–152.
  • Lee CL, Lento WE, Castle KD, Chao NJ, Kirsch DG. 2014. Inhibiting glycogen synthase kinase-3 mitigates the hematopoietic acute radiation syndrome in mice. Radiat Res. 181:445–451.
  • Li XH, Fu D, Latif NH, Mullaney CP, Ney PH, Mog SR, Whitnall MH, Srinivasan V, Xiao M. 2010. Delta-tocotrienol protects mouse and human hematopoietic progenitors from gamma-irradiation through extracellular signal-regulated kinase/mammalian target of rapamycin signaling. Haematologica. 95:1996–2004.
  • Li XH, Ghosh SP, Ha CT, Fu D, Elliott TB, Bolduc DL, Villa V, Whitnall MH, Landauer MR, Xiao M. 2013. Delta-tocotrienol protects mice from radiation-induced gastrointestinal injury. Radiat Res. 180:649–657.
  • Li XH, Ha CT, Fu D, Landauer MR, Ghosh SP, Xiao M. 2015. Delta-tocotrienol suppresses radiation-induced microRNA-30 and protects mice and human CD34+ cells from radiation injury. PLoS One. 10:e0122258.
  • Li ZT, Wang LM, Yi LR, Jia C, Bai F, Peng RJ, Yu ZY, Xiong GL, Xing S, Shan YJ, et al. 2017. Succinate ester derivative of δ-tocopherol enhances the protective effects against (60)Co γ-ray-induced hematopoietic injury through granulocyte colony-stimulating factor induction in mice. Sci Rep. 7:40380.
  • Lu L, Dong J, Li D, Zhang J, Fan S. 2016. 3,3′-diindolylmethane mitigates total body irradiation-induced hematopoietic injury in mice. Free Radic Biol Med. 99:463–471.
  • Lu X, Nurmemet D, Bolduc DL, Elliott TB, Kiang JG. 2013. Radioprotective effects of oral 17-dimethylaminoethylamino-17-demethoxygeldanamycin in mice: bone marrow and small intestine. Cell Biosci. 3:36.
  • Ma J, Hou Y, Han D, Zhang M, Chen C, Zhang B, Zhang Z, Wang X, Yang S, Guo Y, et al. 2013. Fibroblast growth factor-peptide promotes bone marrow recovery after irradiation. Adv Exp Med Biol. 765:155–161.
  • Maclachlan T, Narayanan B, Gerlach VL, Smithson G, Gerwien RW, Folkerts O, Fey EG, Watkins B, Seed T, Alvarez E. 2005. Human fibroblast growth factor 20 (FGF-20; CG53135-05): a novel cytoprotectant with radioprotective potential. Int J Radiat Biol. 81:567–579.
  • MacVittie TJ, Farese AM, Jackson W. 3rd 2005. Defining the full therapeutic potential of recombinant growth factors in the post radiation-accident environment: the effect of supportive care plus administration of G-CSF. Health Phys. 89:546–555.
  • Mansour HH, Tawfik SS. 2012. Early treatment of radiation-induced heart damage in rats by caffeic acid phenethyl ester. Eur J Pharmacol. 692:46–51.
  • Maurya DK, Salvi VP, Nair CK. 2005. Radiation protection of DNA by ferulic acid under in vitro and in vivo conditions. Mol Cell Biochem. 280:209–217.
  • McCarty MF, O’Keefe JH, DiNicolantonio JJ. 2016. Pentoxifylline for vascular health: a brief review of the literature. Open Heart. 3:e000365.
  • McVicar SD, Rayavara K, Carney DH. 2017. Radiomitigation and tissue repair activity of systemically administered therapeutic peptide TP508 is enhanced by PEGylation. AAPS J. 19:743–753.
  • Medhora M, Gao F, Jacobs ER, Moulder JE. 2012. Radiation damage to the lung: mitigation by angiotensin-converting enzyme (ACE) inhibitors. Respirology. 17:66–71.
  • Medhora M, Gao F, Wu Q, Molthen RC, Jacobs ER, Moulder JE, Fish BL. 2014. Model development and use of ACE inhibitors for preclinical mitigation of radiation-induced injury to multiple organs. Radiat Res. 182:545–555.
  • Meydan D, Gursel B, Bilgici B, Can B, Ozbek N. 2011. Protective effect of lycopene against radiation-induced hepatic toxicity in rats. J Int Med Res. 39:1239–1252.
  • Miller AC, Cohen S, Stewart M, Rivas R, Lison P. 2011. Radioprotection by the histone deacetylase inhibitor phenylbutyrate. Radiat Environ Biophys. 50:585–596.
  • Miller RC, Murley JS, Grdina DJ. 2014. Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs. Radiat Res. 181:464–470.
  • Mitchell GC, Fillinger JL, Sittadjody S, Avila JL, Burd R, Limesand KH. 2010. IGF1 activates cell cycle arrest following irradiation by reducing binding of DeltaNp63 to the p21 promoter. Cell Death Dis. 1:e50.
  • Moulder JE, Cohen EP. 2007. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin Radiat Oncol. 17:141–148.
  • Moulder JE, Cohen EP, Fish BL. 2011. Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation. Radiat Res. 175:29–36.
  • Moulder JE, Cohen EP, Fish BL, Hill P. 1993. Prophylaxis of bone marrow transplant nephropathy with captopril, an inhibitor of angiotensin-converting enzyme. Radiat Res. 136:404–407.
  • Nadir Y, Brenner B. 2012. Thrombotic complications associated with stem cell transplantation. Blood Rev. 26:183–187.
  • Nagayama H, Misawa K, Tanaka H, Ooi J, Iseki T, Tojo A, Tani K, Yamada Y, Kodo H, Takahashi TA, et al. 2002. Transient hematopoietic stem cell rescue using umbilical cord blood for a lethally irradiated nuclear accident victim. Bone Marrow Transplant. 29:197–204.
  • National Academy of Sciences. 1999. Potential radiation exposure in military operations. In: Thaul S, O’Maonaigh H, editors. Protecting the soldier before, during, and after. N.W. Washington (DC): National Academy Press.
  • National Academy of Sciences. 2009. Assessing medical preparedness to respond to a terrorist nuclear event. In: Benjamin GC, McGeary M, McCutchen SR, editors. Workshop report. N. W. Washington (DC): National Academies Press.
  • Nesterenko VB, Nesterenko AV, Babenko VI, Yerkovich TV, Babenko IV. 2004. Reducing the 137Cs-load in the organism of Chernobyl children with apple-pectin. Swiss Med Wkly. 134:24–27.
  • Okunieff P, Wu T, Huang K, Ding I. 1996. Differential radioprotection of three mouse strains by basic or acidic fibroblast growth factor. Br J Cancer Suppl. 27:S105–S108.
  • Okunieff P, Xu J, Hu D, Liu W, Zhang L, Morrow G, Pentland A, Ryan JL, Ding I. 2006. Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int J Radiat Oncol Biol Phys. 65:890–898.
  • Olcina MM, Giaccia AJ. 2016. Reducing radiation-induced gastrointestinal toxicity: the role of the PHD/HIF axis. J Clin Invest. 126:3708–3715.
  • Olszewska-Pazdrak B, McVicar SD, Rayavara K, Moya SM, Kantara C, Gammarano C, Olszewska P, Fuller GM, Sower LE, Carney DH. 2016. Nuclear countermeasure activity of TP508 linked to restoration of endothelial function and acceleration of DNA repair. Radiat Res. 186:162–174.
  • Ostrau C, Hulsenbeck J, Herzog M, Schad A, Torzewski M, Lackner KJ, Fritz G. 2009. Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo. Radiother Oncol. 92:492–499.
  • Ozturk B, Egehan I, Atavci S, Kitapci M. 2004. Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial. Int J Radiat Oncol Biol Phys. 58:213–219.
  • Paoluzzi L, Figg WD. 2004. Histone deacetylase inhibitors are potent radiation protectants. Cancer Biol Ther. 3:612–613.
  • Pathak R, Cheema AK, Boca SM, Krager KJ, Hauer-Jensen M, Aykin-Burns N. 2015. Modulation of radiation response by the tetrahydrobiopterin pathway. Antioxidants (Basel). 4:68–81.
  • Pathak R, Pawar SA, Fu Q, Gupta PK, Berbee M, Garg S, Sridharan V, Wang W, Biju PG, Krager KJ, et al. 2014. Characterization of transgenic Gfrp knock-in mice: implications for tetrahydrobiopterin in modulation of normal tissue radiation responses. Antioxid Redox Signal. 20:1436–1446.
  • Patil R, Szabo E, Fells JI, Balogh A, Lim KG, Fujiwara Y, Norman DD, Lee SC, Balazs L, Thomas F, et al. 2015. Combined mitigation of the gastrointestinal and hematopoietic acute radiation syndromes by an LPA2 receptor-specific nonlipid agonist. Chem Biol. 22:206–216.
  • Peebles DD, Soref CM, Copp RR, Thunberg AL, Fahl WE. 2012. ROS-scavenger and radioprotective efficacy of the new PrC-210 aminothiol. Radiat Res. 178:57–68.
  • Perman V, Cronkite EP, Bond VP, Sorensen DK. 1962. The regenerative ability of hemopoietic tissue following lethal x-irradiation in dogs. Blood. 19:724–737.
  • Prockop DJ. 2013. Further proof for an unpopular concept: a single cell from bone marrow can serve as a stem cell for both hematopoiesis and osteogenesis. Mol Ther. 21:1116–1117.
  • Prockop DJ, Brenner M, Fibbe WE, Horwitz E, Le Blanc K, Phinney DG, Simmons PJ, Sensebe L, Keating A. 2010. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy. 12:576–578.
  • Prockop DJ, Gregory CA, Spees JL. 2003. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci USA. 100(Suppl.1):11917–11923.
  • Reed GA, Arneson DW, Putnam WC, Smith HJ, Gray JC, Sullivan DK, Mayo MS, Crowell JA, Hurwitz A. 2006. Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3′-diindolylmethane. Cancer Epidemiol Biomarkers Prev. 15:2477–2481.
  • Reed GA, Sunega JM, Sullivan DK, Gray JC, Mayo MS, Crowell JA, Hurwitz A. 2008. Single-dose pharmacokinetics and tolerability of absorption-enhanced 3,3′-diindolylmethane in healthy subjects. Cancer Epidemiol Biomarkers Prev. 17:2619–2624.
  • Robbins ME, Diz DI. 2006. Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. Int J Radiat Oncol Biol Phys. 64:6–12.
  • Robbins ME, Hopewell JW. 1986. Physiological factors effecting renal radiation tolerance: a guide to the treatment of late effects. Br J Cancer Suppl. 7:265–267.
  • Rosenbloom AL. 2009. Mecasermin (recombinant human insulin-like growth factor I). Adv Ther. 26:40–54.
  • Rotolo J, Stancevic B, Zhang J, Hua G, Fuller J, Yin X, Haimovitz-Friedman A, Kim K, Qian M, Cardo-Vila M, et al. 2012. Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice. J Clin Invest. 122:1786–1790.
  • Rube CE, Wilfert F, Uthe D, Schmid KW, Knoop R, Willich N, Schuck A, Rube C. 2002. Modulation of radiation-induced tumour necrosis factor alpha (TNF-alpha) expression in the lung tissue by pentoxifylline. Radiother Oncol. 64:177–187.
  • Ryaby JT, Sheller MR, Levine BP, Bramlet DG, Ladd AL, Carney DH. 2006. Thrombin peptide TP508 stimulates cellular events leading to angiogenesis, revascularization, and repair of dermal and musculoskeletal tissues. J Bone Joint Surg Am. 88(Suppl.3):132–139.
  • Saada HN, Rezk RG, Eltahawy NA. 2010. Lycopene protects the structure of the small intestine against gamma-radiation-induced oxidative stress. Phytother Res. 24(Suppl.2):S204–S208.
  • Sabisz M, Skladanowski A. 2008. Modulation of cellular response to anticancer treatment by caffeine: inhibition of cell cycle checkpoints, DNA repair and more. Curr Pharm Biotechnol. 9:325–336.
  • Saha S, Bhanja P, Kabarriti R, Liu L, Alfieri AA, Guha C. 2011. Bone marrow stromal cell transplantation mitigates radiation-induced gastrointestinal syndrome in mice. PLoS One. 6:e24072.
  • Sato T, Kinoshita M, Yamamoto T, Ito M, Nishida T, Takeuchi M, Saitoh D, Seki S, Mukai Y. 2015. Treatment of irradiated mice with high-dose ascorbic acid reduced lethality. PLoS One. 10:e0117020.
  • Satyamitra M, Kulkarni S, Ghosh SP, Mullaney C, Condliffe D, Srinivasan V. 2011a. Hematopoietic recovery and amelioration of radiation-induced lethality by the vitamin E isoform, delta-tocotrienol. Radiat Res. 175:736–745.
  • Satyamitra M, Lombardini E, Graves J, 3rd, Mullaney C, Ney P, Hunter J, Johnson K, Tamburini P, Wang Y, Springhorn JP, et al. 2011b. A TPO receptor agonist, ALXN4100TPO, mitigates radiation-induced lethality and stimulates hematopoiesis in CD2F1 mice. Radiat Res. 175:746–758.
  • Satyamitra M, Lombardini E, Peng T, Devore D, Graves J 3rd, Mullaney C, Ney P, Srinivasan V. 2013. Preliminary nonclinical toxicity, pharmacokinetics, and pharmacodynamics of ALXN4100TPO, a thrombopoietin receptor agonist, in CD2F1 mice. Int J Toxicol. 32:100–112.
  • Satyamitra M, Ney P, Graves J 3rd, Mullaney C, Srinivasan V. 2012. Mechanism of radioprotection by delta-tocotrienol: pharmacokinetics, pharmacodynamics and modulation of signalling pathways. BJR. 85:e1093–e1103.
  • Schubert D, Dargusch R, Raitano J, Chan SW. 2006. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun. 342:86–91.
  • Schuster MW, Beveridge R, Frei-Lahr D, Abboud CN, Cruickshank S, Macri M, Menchaca D, Holden J, Waller EK. 2002. The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation. Exp Hematol. 30:1044–1050.
  • Semont A, Francois S, Mouiseddine M, Francois A, Sache A, Frick J, Thierry D, Chapel A. 2006. Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury. Adv Exp Med Biol. 585:19–30.
  • Shakhov AN, Singh VK, Bone F, Cheney A, Kononov Y, Krasnov P, Bratanova-Toshkova TK, Shakhova VV, Young J, Weil MM, et al. 2012. Prevention and mitigation of acute radiation syndrome in mice by synthetic lipopeptide agonists of Toll-like receptor 2 (TLR2). PLoS One. 7:e33044.
  • Shalit I, Kletter Y, Weiss K, Gruss T, Fabian I. 1997. Enhanced hematopoiesis in sublethally irradiated mice treated with various quinolones. Eur J Haematol. 58:92–98.
  • Shi J, Wang L, Lu Y, Ji Y, Wang Y, Dong K, Kong X, Sun W. 2017. Protective effects of sea buckthorn pulp and seed oils against radiation-induced acute intestinal injury. J Radiat Res. 58:24–32.
  • Shimizu S, Ishii M, Miyasaka Y, Wajima T, Negoro T, Hagiwara T, Kiuchi Y. 2005. Possible involvement of hydroxyl radical on the stimulation of tetrahydrobiopterin synthesis by hydrogen peroxide and peroxynitrite in vascular endothelial cells. Int J Biochem Cell Biol. 37:864–875.
  • Singh PK, Wise SY, Ducey EJ, Fatanmi OO, Elliott TB, Singh VK. 2012a. Alpha-tocopherol succinate protects mice against radiation-induced gastrointestinal injury. Radiat Res. 177:133–145.
  • Singh VK, Beattie LA, Seed TM. 2013a. Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures. J Radiat Res. 54:973–988.
  • Singh VK, Brown DS, Kao TC. 2009. Tocopherol succinate: a promising radiation countermeasure. Int Immunopharmacol. 9:1423–1430.
  • Singh VK, Brown DS, Kao TC. 2010a. Alpha-tocopherol succinate protects mice from gamma-radiation by induction of granulocyte-colony stimulating factor. Int J Radiat Biol. 86:12–21.
  • Singh VK, Brown DS, Kao TC, Seed TM. 2010b. Preclinical development of a bridging therapy for radiation casualties. Exp Hematol. 38:61–70.
  • Singh VK, Ducey EJ, Fatanmi OO, Singh PK, Brown DS, Purmal A, Shakhova VV, Gudkov AV, Feinstein E, Shakhov A. 2012b. CBLB613: a TLR 2/6 agonist, natural lipopeptide of Mycoplasma arginini, as a novel radiation countermeasure. Radiat Res. 177:628–642.
  • Singh VK, Garcia M, Wise SY, Seed TM. 2016a. Medical countermeasures for unwanted CBRN exposures: Part I chemical and biological threats with review of recent countermeasure patents. Expert Opin Ther Pat. 26:1431–1447.
  • Singh VK, Parekh VI, Brown DS, Kao TC, Mog SR. 2011. Tocopherol succinate: modulation of antioxidant enzymes and oncogene expression, and hematopoietic recovery. Int J Radiat Oncol Biol Phys. 79:571–578.
  • Singh VK, Pollard HB. 2015. Patents for Toll-like receptor ligands as radiation countermeasures for acute radiation syndrome. Expert Opin Ther Pat. 25:1085–1092.
  • Singh VK, Romaine PL, Newman VL. 2015. Biologics as countermeasures for acute radiation syndrome: where are we now? Expert Opin Biol Ther. 15:465–471.
  • Singh VK, Romaine PL, Newman VL, Seed TM. 2016b. Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents. Expert Opin Ther Pat. 26:1399–1408.
  • Singh VK, Singh PK, Wise SY, Posarac A, Fatanmi OO. 2013b. Radioprotective properties of tocopherol succinate against ionizing radiation in mice. J Radiat Res. 54:210–220.
  • Singh VK, Wise SY, Fatanmi OO, Scott J, Romaine PL, Newman VL, Verma A, Elliott TB, Seed TM. 2014a. Progenitors mobilized by gamma-tocotrienol as an effective radiation countermeasure. PLoS One. 9:e114078.
  • Singh VK, Wise SY, Scott JR, Romaine LP, Newman VL, Fatanmi OO. 2014b. Radioprotective efficacy of delta-tocotrienol, a vitamin E isoform, is mediated through granulocyte colony-stimulating factor. Life Sci. 98:113–122.
  • Singh VK, Wise SY, Singh PK, Ducey EJ, Fatanmi OO, Seed TM. 2012c. Alpha-tocopherol succinate- and AMD3100-mobilized progenitors mitigate radiation-induced gastrointestinal injury in mice. Exp Hematol. 40:407–417.
  • Soref CM, Hacker TA, Fahl WE. 2012. A new orally active, aminothiol radioprotector-free of nausea and hypotension side effects at its highest radioprotective doses. Int J Radiat Oncol Biol Phys. 82:e701–e707.
  • Sureban SM, May R, Qu D, Chandrakesan P, Weygant N, Ali N, Lightfoot SA, Ding K, Umar S, Schlosser MJ, et al. 2015. Dietary pectin increases intestinal crypt stem cell survival following radiation injury. PLoS One. 10:e0135561.
  • Taniguchi CM, Miao YR, Diep AN, Wu C, Rankin EB, Atwood TF, Xing L, Giaccia AJ. 2014. PHD inhibition mitigates and protects against radiation-induced gastrointestinal toxicity via HIF2. Sci Transl Med. 6:236ra264.
  • Thomas LJ, Round SM, Naylor SR, Forsberg EM, Borelli KM, Pilsmaker CD, Gergel LE, Marsh HC, Keller T. 2013. Radioprotective and radiomitigative efficacy of Flt3 ligand in a murine model of acute raiation injury. FASEB J. 27:1181.
  • U.S. Food and Drug Administration. 2012. FDA approves Signifor, a new orphan drug for Cushing’s disease [Internet]. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm332351.htm
  • U.S. Food and Drug Administration. 2013. FDA approves new drug for the chronic management of some urea cycle disorders [Internet]. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm337639.htm
  • van der Veen SJ, Ghobadi G, de Boer RA, Faber H, Cannon MV, Nagle PW, Brandenburg S, Langendijk JA, van Luijk P, Coppes RP. 2015. ACE inhibition attenuates radiation-induced cardiopulmonary damage. Radiother Oncol. 114:96–103.
  • Venkateswaran K, Shrivastava A, Agrawala PK, Prasad A, Kalra N, Pandey PR, Manda K, Raj HG, Parmar VS, Dwarakanath BS. 2016. Mitigation of radiation-induced hematopoietic injury by the polyphenolic acetate 7, 8-diacetoxy-4-methylthiocoumarin in mice. Sci Rep. 6:37305.
  • Wang C, Zhang B, Wang S, Zhang J, Liu Y, Wang J, Fan Z, Lv Y, Zhang X, He L, et al. 2015a. Recombinant human thrombopoietin promotes hematopoietic reconstruction after severe whole body irradiation. Sci Rep. 5:12993.
  • Wang X, Wei L, Cramer JM, Leibowitz BJ, Judge C, Epperly M, Greenberger J, Wang F, Li L, Stelzner MG, Dunn JC, Martin MG, Lagasse E, Zhang L, Yu J. 2015b. Pharmacologically blocking p53-dependent apoptosis protects intestinal stem cells and mice from radiation. Sci Rep. 5:8566.
  • Ward WF, Kim YT, Molteni A, Solliday NH. 1988. Radiation-induced pulmonary endothelial dysfunction in rats: modification by an inhibitor of angiotensin converting enzyme. Int J Radiat Oncol Biol Phys. 15:135–140.
  • Ward WF, Molteni A, Ts’ao C, Hinz JM. 1990. The effect of Captopril on benign and malignant reactions in irradiated rat skin. Br J Radiol. 63:349–354.
  • Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, Tsu H, Confer DL, Coleman CN, Seed T, et al. 2004. Medical management of the acute radiation syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med. 140:1037–1051.
  • Wei L, Leibowitz BJ, Wang X, Epperly M, Greenberger J, Zhang L, Yu J. 2016. Inhibition of CDK4/6 protects against radiation-induced intestinal injury in mice. J Clin Invest. 126:4076–4087.
  • Weiss JF, Landauer MR. 2000. Radioprotection by antioxidants. Ann N Y Acad Sci. 899:44–60.
  • Weiss JF, Landauer MR. 2003. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology. 189:1–20.
  • Williams JP, Hernady E, Johnston CJ, Reed CM, Fenton B, Okunieff P, Finkelstein JN. 2004. Effect of administration of lovastatin on the development of late pulmonary effects after whole-lung irradiation in a murine model. Radiat Res. 161:560–567.
  • Xu G, Wu H, Zhang J, Li D, Wang Y, Wang Y, Zhang H, Lu L, Li C, Huang S, et al. 2015. Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice. Free Radic Biol Med. 87:15–25.
  • Xu L, Xiong S, Guo R, Yang Z, Wang Q, Xiao F, Wang H, Pan X, Zhu M. 2014. Transforming growth factor β3 attenuates the development of radiation-induced pulmonary fibrosis in mice by decreasing fibrocyte recruitment and regulating IFN-γ/IL-4 balance. Immunol Lett. 162:27–33.
  • Xu PT, Maidment BW 3rd Antonic V, Jackson IL, Das S, Zodda A, Zhang X, Seal S, Vujaskovic Z. 2016. Cerium oxide nanoparticles: a potential medical countermeasure to mitigate radiation-induced lung injury in CBA/J mice. Radiat Res. 185:516–526.
  • Yamamoto T, Kinoshita M, Shinomiya N, Hiroi S, Sugasawa H, Matsushita Y, Majima T, Saitoh D, Seki S. 2010. Pretreatment with ascorbic acid prevents lethal gastrointestinal syndrome in mice receiving a massive amount of radiation. J Radiat Res. 51:145–156.
  • Yen SH, Wang LW, Lin YH, Jen YM, Chung YL. 2012. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 82:1463–1470.
  • Yildiz OG, Soyuer S, Saraymen R, Eroglu C. 2008. Protective effects of caffeic acid phenethyl ester on radiation induced lung injury in rats. Clin Invest Med. 31:E242–24E247.
  • Zakheim RM, Mattioli L, Molteni A, Mullis KB, Bartley J. 1975. Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat. Lab Invest. 33:57–61.
  • Zellefrow CD, Sharlow ER, Epperly MW, Reese CE, Shun T, Lira A, Greenberger JS, Lazo JS. 2012. Identification of druggable targets for radiation mitigation using a small interfering RNA screening assay. Radiat Res. 178:150–159.
  • Zhang K, Tian Y, Yin L, Zhang M, Beck LA, Zhang B, Okunieff P, Zhang L, Vidyasagar S. 2011. Fibroblast growth factor-peptide improves barrier function and proliferation in human keratinocytes after radiation. Int J Radiat Oncol Biol Phys. 81:248–254.
  • Zhao J, Kim KA, De Vera J, Palencia S, Wagle M, Abo A. 2009. R-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt/beta-catenin pathway. Proc Natl Acad Sci USA. 106:2331–2336.
  • Zhao X, Yang H, Jiang G, Ni M, Deng Y, Cai J, Li Z, Shen F, Tao X. 2014. Simvastatin attenuates radiation-induced tissue damage in mice. J Radiat Res. 55:257–264.
  • Zheng K, Wu W, Yang S, Huang L, Chen J, Gong C, Fu Z, Lin R, Tan J. 2016. Treatment of radiation-induced acute intestinal injury with bone marrow-derived mesenchymal stem cells. Exp Ther Med. 11:2425–2431.
  • Zhou D, Deoliveira D, Kang Y, Choi SS, Li Z, Chao NJ, Chen BJ. 2013. Insulin-like growth factor 1 mitigates hematopoietic toxicity after lethal total body irradiation. Int J Radiat Oncol Biol Phys. 85:1141–1148.